Calvin joined Sofinnova BioEquities as an Analyst in 2026. He focuses on public investments in healthcare services.
Prior to Sofinnova, Calvin was an Analyst at Millennium Management in New York, where he led investment research and due diligence across a broad range of healthcare sectors, including contract research organizations, hospitals, laboratories, and managed care organizations. Before joining Millennium, he served as Vice President of Managed Care & Facilities Equity Research at JPMorgan Chase, developing investment theses, built financial models, published research reports, and advised institutional investors on healthcare industry trends and company performance. Earlier in their career, Calvin held healthcare equity research roles at TD Cowen and FBR Capital Markets and began his professional career at EY as a Structured Finance Valuation Analyst.
Calvin received his Bachelor of Science in Accounting from Binghamton University.